Abstract-Structural Genomics is an international effort to determine the three-dimensional shapes of all important biological macromolecules, with a primary focus on proteins. Target proteins should be selected according to a strategy that is medically and biologically relevant, of good financial value, and tractable. In 2003, we presented the "Pfam5000" strategy, which involves selecting the 5,000 most important families from the Pfam database as sources for targets. In this update, we show that although both the Pfam database and the number of sequenced genomes have increased in size, the expected benefits of the Pfam5000 strategy have not changed substantially. Solving the structures of proteins from the 5,000 largest Pfam families would allow accurate fold assignment for approximately 65% of all prokaryotic proteins (covering 54% of residues) and 63% of eukaryotic proteins (42% of residues). Fewer than 2,300 of the largest families on this list remain to be solved, making the project feasible in the next five years given the expected throughput to be achieved in the production phase of the Protein Structure Initiative.
I. INTRODUCTION
TRUCTURAL genomics aims at the discovery, analysis, and dissemination of three-dimensional structures of protein, RNA, and other biological macromolecules representing the entire range of structural diversity found in nature [1] [2] [3] [4] [5] . In the United States, the National Institutes of Health are supporting structural genomics projects at 9 pilot centers through the Protein Structure Initiative (PSI). The primary focus at the PSI centers is on proteins, with targets for experimental structure determination being conducted independently at each center. Beginning later this year, the PSI project moves into a production phase, with the total throughput expected to increase to approximately 600-1,000 protein structures per year. In the production phase, the majority of targets for all centers are expected to be chosen using a more centralized strategy (http://grants2.nih.gov/ grants/guide/rfa-files/RFA-GM-05-001.html) [6] .
In November 2003, in order to help inform future strategic decisions, we quantified the potential impact that several proposed strategies for target selection will have on our future ability to model the structures of proteins from a wide range of sequenced genomes [7] . We examined genome-centric strategies such solving the structures of all proteins from a single pathogenic genomes [8, 9] or a comparable number of human proteins. We found that these strategies would have little impact on our structural knowledge of other proteomes, since a significant fraction of each proteome is classified in small families, which may have little overlap with other species of interest. As an alternative, we proposed the "Pfam5000" strategy, or choosing targets from a regularly updated index of the 5,000 most important, tractable families in the Pfam database [10] at a given point in time.
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In the original report, we projected that successful solution of targets from the largest 5,000 Pfam families would accurate fold assignment for approximately 68% of all prokaryotic proteins (covering 59% of residues) and 61% of eukaryotic proteins (40% of residues). More fine-grained coverage which would allow accurate modeling of these proteins would require an order of magnitude more targets. The Pfam5000 strategy may be modified in several ways, for example to focus on larger families, bacterial sequences, or eukaryotic sequences; as long as secondary consideration is given to large families within Pfam, coverage results vary only slightly.
Since our first analysis, Pfam has grown by over 1,000 families and numerous additional genomes have been sequenced. In this report, we repeat the analysis on the expanded data set in order to examine the stability of our projections. We find that the conclusions in the original study are still valid, despite major changes in the data we analyzed. 
II. DATA AND METHODS

A. Pfam
This study is based on Pfam 16.0, released in October 2004. Our previous study [7] 
B. The Pfam5000
The specific families chosen for the Pfam5000 should be based on their importance and tractability. The simplest definition for importance is size: the number of proteins that belong to a family may be taken as a proxy for its significance. As we showed in the original study [7] , so long as size is a secondary criterion in the current Pfam database, the selected set of proteins is relatively insensitive to a wide variety of primary criteria, including presence of representatives in particular proteomes of interest. In the current analysis, we present results on a version of the Pfam5000 biased towards currently solved structures. This means that the Pfam5000 includes all families with a structure currently solved. Families without a solved structure are added in decreasing order by size to fill out the remaining families.
C. Proteome Database
In the original study, we measured progress on structural completion of proteomes from the Proteome Analysis database at the European Bioinformatics Institute [11] . This database has since been merged into the Integr8 database [12] . Integr8 version 12 was used in this analysis.
The Integr8 database contains annotations for 238 complete proteomes, including 19 eukaryotes. This is almost double the number of proteomes we analyzed in our previous study of 131 species and 10 eukaryotes. Species added include several new types of yeast, the malaria parasite, and partial annotation of the zebrafish. The proteome for each organism is composed of proteins curated from the Swiss-Prot and TrEMBL databases. All proteins were annotated with hidden Markov models [13, 14] 
D. Measures of Progress
The ultimate goal of structural genomics is to provide structural information for the complete repertoire of biological macromolecules. We measure progress towards that goal as "coverage." Coverage of a proteome is the fraction of its sequences or residues that are covered. Persequence coverage is measured as the fraction of sequences that have at least one domain that belongs to a family with a representative whose structure is to be experimentally characterized; this would allow the relevant domain to have its fold assigned [16] [17] [18] .
To identify Pfam families with currently known structures, we ran all Pfam-A models against our database of sequences of known structure. This database includes sequences of all proteins currently in the PDB [19] , sequences of proteins on hold in the PDB (when made available by the authors), and sequences of proteins reported as solved by structural genomics centers in the TargetDB database [20] . This database was updated on 21 March 2005. The "trusted cutoff" for each Pfam family was used as a cutoff for determining which hits were significant.
Per-residue coverage by Pfam families was calculated using the beginning and end residues annotated in the Proteome Analysis databases. All residues between the endpoints were annotated as part of the matching family, ignoring any potential gaps. In the original report [7] , we tested several variant methods of calculating per-residue coverage of proteomes. The simplest method is to divide the total number of residues in regions matched by Pfam by the total length of all proteins in the proteome. However, we found it more informative to measure progress on the portion of the proteome expected to be interesting and tractable to study under high-throughput experimental conditions. In the latter calculation of per-residue coverage, we ignore unmatched regions of the proteome predicted to be in transmembrane regions, low complexity regions, or coiled coil, as well as short regions of fewer than 50 consecutive unmatched residues between transmembrane regions and/or Pfam hits. This variant of per-residue coverage was used in the current study.
The "seg" program [21] (version dated 5/24/2000) was run on all sequences in Integr8 to identify putative low complexity regions. The "ccp" program [22] (version dated 6/14/1998) was used to predict coiled coil regions in all sequences, and TMHMM 2.0a [23] was used to predict the locations of transmembrane helices. Default options were used for all programs. 
III. RESULTS
A. Known Structures in Pfam
Currently, 2729 of 7677 (36%) of Pfam families have at least one member of known structure. We identified the earliest structural representative from each family using the deposition dates of the structures. We found that the rate of structural characterization of new families rose steadily throughout the 1990s, but has leveled off at around 20 new families per month since 1999 (Fig. 2a) , even as the total number of structures solved continues to increase exponentially. The fraction of Pfam families with known structure (Fig. 2b) has varied over recent years from approximately 50% to as low as 30%, and is currently increasing as new families are being solved faster than the rate at which new families are classified in Pfam.
B. Increase in Proteome Coverage
We calculated the coverage of proteomes in Integr8 by families with currently known structures. Results for selected proteomes are given in Table I , and results for all 238 proteomes are available from the authors upon request. Several results are apparent from the table. First, structural coverage of most prominent organisms has increased by 4 to 7% in the 1.5 years since the original study. Second, the average coverage of prokaryotes has increased by 4.8%, from 46.5% of all proteins to 51.3%., while the percentage of residues covered has increased from 38.3% to 43.8% (a 5.5% increase). The average increase is lower than for the organisms listed in the table, because the average includes many proteomes sequenced in the past several years. These organisms tend to have been less well studied than the prominent organisms listed in the table (e.g., E. coli).
Coverage figures for most prominent eukaryotes listed in the table have increased by 4 to 6% over the past 1.5 years. The average coverage of eukaryotes has increased by 4.5%, from 47.2% of all proteins to 51.7%., while the percentage of residues covered has increased from 30.4% to 33.1% (a 2.7% increase). The proteome of the malaria parasite, P. falciparum, stands out as particularly poorly covered by currently known structures. As observed in the original study, per-residue coverage of eukaryotes is lower than for prokaryotes even at comparable per-protein coverage; this difference is presumably due to eukaryotes having more multi-domain proteins. Table II shows projected coverage by the families in the current Pfam5000, compared to the 5,000 families from the original study 1.5 years ago. Both sets were biased towards known structures; thus, the current Pfam5000 is composed of the 2,729 families with currently known structures, along with the 2,271 largest families that do not have a current structural representative. The original set contained 2,108 families of known structure and the remaining 2,892 largest families.
C. Stability of Coverage Projections
The stability of the projections is quite good: for the prominent organisms listed in the table, projected coverage at the completion of structural characterization of the Pfam5000 has generally increased by 1-2%, with only one organism (M. jannaschii) showing a projected decrease. The slight increase in most projections is due to the classification of additional large families in Pfam: these large families replaced smaller families in the Pfam5000, allowing slightly more coverage projected upon completion.
More importantly, the average projection for coverage across a wide range of prokaryotic and eukaryotic organisms has remained stable, despite a near-doubling (131 to 238) in the number of sequenced organisms we analyzed.
In the previous study, we reported unweighted statistics on average projected coverage for organisms. Since that time, a number of very small eukaryotic genomes have been sequenced, including Cryptococcus neoformans and Guillardia theta. We therefore report statistics weighted by proteome size (the number of proteins for per-protein statistics, and the number of residues for per-residue statistics). We expect completion at least one structure from each of the current Pfam5000 families to allow accurate fold assignment for approximately 65% of all prokaryotic proteins (covering 54% of residues) and 63% of eukaryotic proteins (42% of residues). 
IV. DISCUSSION
The families in Pfam5000 represent a tractable yet extremely useful set of targets to study in the production phase of the PSI. If all structures in Pfam5000 were solved, we would have at least partial information on the folds of nearly 2/3 of all then-known proteins. This goal appears to be feasible within the next five years, especially as the number of families of known structure has already increased by over 600 in the 1.5 years since our initial study. Completion of the largest 5,000 families would have a broad impact on our structural understanding of both currently sequenced genomes and on genomes yet to be sequenced. If modeling and threading methods enjoy similar advances in the next five years, we will be able to produce accurate models for these proteins as well as fold assignments.
Given that the projections appear stable even as the number of sequenced proteomes continues to increase, further prioritization of the families would be useful. We showed in our original study that the projected coverage results are relatively insensitive to specific secondary methods of prioritization, as long as family size remains the main criterion. Further prioritization of the large families most likely to yield significant biomedical breakthroughs would also be of great interest.
Another major problem not yet examined is prioritization by tractability. Most groups assume that low complexity, coiled coil, and transmembrane proteins are less tractable to study by high throughput experimental methods. It would be useful to prioritize the Pfam5000 families according to predicted tractability, in order to get the most results out of our current state-of-the-art technology for high throughput experimentation. Some methods to prioritize individual family members for high-throughput experimentation have already been developed (e.g., prioritizing proteins from thermophiles and halophiles), and further systematic development of these methods will also be essential to achieving further breakthroughs in experimental throughput.
